Navigation Links
Acuo Technologies Updates the Universal Clinical Platform
Date:2/21/2012

BLOOMINGTON, Minn., Feb. 21, 2012 /PRNewswire/ -- Acuo Technologies®, the leader in high-performance software and services for intelligent clinical content management and data migration, is pleased to announce the latest release of its award winning Universal Clinical Platform (UCP3).  Version 6.0 adds advanced features required for next generation Vendor Neutral Archive solutions with standards based clinical registry and repository capabilities, unmatched infrastructure versatility, and increased performance and scalability.

AcuoAccess™ and AcuoWorkflow™ are introduced with this release.  These components offer an intelligence layer based on Web Services and RESTful APIs that facilitate enterprise workflow, a comprehensive tag mapping platform with input, output and query support, and access to DICOM and non-DICOM data, including support for the MINT protocol.  "Acuo is pleased to offer next generation capabilities by exposing its enterprise VNA collaboration and orchestration capabilities through Web Services," stated Shannon Werb, Chief Operating Officer.  "This functionality will allow Acuo's customers and partners to experience unprecedented access, control and flexibility – resulting in true data ownership." 

UCP3 introduces enterprise Master Patient Index capabilities, based on the PIX and PDQ IHE actors along with a "plugin" architecture that provides a flexible extension to varying MPI requirements within complex customer and HIE environments.  The cloud enabled solution is further augmented by integrations to third party cloud storage providers such as Nirvanix® and Scality® (based on Amazon S3).

UCP3 version 6.0 enhances non-DICOM support through an innovative enterprise approach based on the IHE XDS.b profile, including and XDS.b Repository and Registry, enabling management of any non-DICOM content in a standard based context.  "Data can be stored and retrieved via the IHE Web Service based transactions or RESTful APIs," stated Razvan Atanasiu, Chief Technical Officer, "this facilitates scalability via streaming and also simplifies the workflow for customers who do not have an IHE infrastructure already deployed.  Acuo has successfully completed the testing of these actors at the 2012 IHE Connectathon and is also proud to announce its participation in the HIMSS IHE Interoperability Showcase."

About Acuo Technologies

Acuo Technologies, with headquarters in Minneapolis, MN, was founded in 2000 with the objective of developing the first enterprise-wide collaborative Universal Clinical Platform (UCP3) solution for medical image content, both DICOM and Non-DICOM. Today, Acuo supports implementations of UCP3 around the world, including locations in Africa, Australia, Canada, New Zealand, South America, United States and the United Kingdom.  For more information on providing superior medical image lifecycle and content management while simplifying operations and reducing costs, visit www.acuotech.com.

DICOM is the registered trademark of the National Electrical Manufacturers Association for its standards publications relating to digital communications of medical information.

 


'/>"/>
SOURCE Acuo Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
3. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
4. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
5. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
6. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
7. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
8. Senesco Technologies Initiates Preclinical Studies for Cancer Target
9. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
10. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
11. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... PawPaws brand pet supplements owned by Whole Health ... the health of felines. The formula is all-natural and is made from Chinese herbs ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):